A year after launching Color Test, breast and ovarian cancer risk test, Color Genomics has expanded Color Test to 30 genes that includes many of the most common hereditary cancers for women and men ...

When a patient has an inherited cancer-associated gene, it is desirable — but not easy — to have other family members tested. In the United States, the difficulty primarily stems from privacy ...

Color, a population genomics and healthcare technology company that counts Apple, Verily and, most recently, Sioux Falls, S.D.-based Sanford Health among its partners, has closed a $75 million funding ...

A startup that sells genetic tests to assess health risks is pulling in millions from high-profile investors, reports CNBC. Burlingame, Calif.-based Color Genomics most recently raised $80 million, ...

Genetic tests for cancer can run thousands of dollars, but Color Genomics plans to change that: it's offering testing for the cancer risk variants BRCA1 and BRCA2 — as well as 17 others — for $249, ...

The Genomics in Cancer Care Market has witnessed substantial growth over the years, fueled by rapid advancements in precision medicine, next-generation sequencing (NGS), and personalized cancer ...

The Consumer Genomics Market has seen remarkable growth in recent years, driven by increasing consumer interest in personalized healthcare, ancestry tracing, and genetic predisposition testing.